1. Native Valve and Native Neo-Sinus Remodeling Following Transcatheter Aortic Valve Replacement.
- Author
-
Yoon J, Gill H, Jelisejevas J, Lai A, Khan JM, Payne GW, Webb JG, Sathananthan J, Seidman MA, Meier D, and Sellers SL
- Subjects
- Humans, Male, Female, Aged, 80 and over, Treatment Outcome, Aged, Time Factors, Transforming Growth Factor beta1 metabolism, Transcatheter Aortic Valve Replacement adverse effects, Transcatheter Aortic Valve Replacement instrumentation, Aortic Valve surgery, Aortic Valve pathology, Aortic Valve physiopathology, Aortic Valve Stenosis surgery, Aortic Valve Stenosis physiopathology, Aortic Valve Stenosis pathology, Aortic Valve Stenosis diagnostic imaging, Calcinosis surgery, Calcinosis pathology
- Abstract
Background: Transcatheter aortic valve replacement (TAVR) pushes aside the diseased native aortic valve and creates a native neo-sinus bordered by the aortic root wall and the displaced native valve. There are limited data on the progression of native valve disease post-TAVR and no previous analysis of the native neo-sinus., Methods: Native aortic valves and native neo-sinus explants obtained post-TAVR were evaluated histologically (hematoxylin and eosin, Movat pentachrome, and Martius Scarlet Blue stains) and by immunohistochemistry (TGF-β1 [transforming growth factor-beta 1], FAP [fibroblast activation protein], and ALP [alkaline phosphatase]) to assess disease mechanisms., Results: Native aortic valves were obtained from 20 patients from 0 to 2583 days (7.08 years) post-TAVR. Native leaflets showed persistent calcific aortic stenosis-like disease activity with positivity for ALP and FAP. Native valve remodeling was observed as changes in architecture evident in explants >1.5 years, which was observed as crumpling of the leaflets. Disease activity was also present in native neo-sinuses with transcatheter heart valve implant durations >1 year with positive staining for TGF-β1, FAP, and ALP. Extensive native neo-sinus remodeling occurred with replacement and filling-in of this space with contiguous extracellular matrix, calcific deposits, and microvessels., Conclusions: Following TAVR, there is ongoing calcific aortic stenosis-like disease with architectural changes to native leaflets and extensive remodeling of the native neo-sinus, evidenced by replacement and contiguous filling-in of the native neo-sinus blood pool space with increasing implant duration. The dynamic nature of these tissues has potential implications for neo-sinus flow, valve degeneration, and re-intervention., Competing Interests: Dr Meier has received an institutional grant from Edwards Lifesciences. Dr Sellers is a consultant for Edwards Lifesciences, Medtronic, and Anteris, and received research support from Edwards Lifesciences, Medtronic, Vivitro Labs, and HeartFlow. H. Gill is supported by the Canadian Institutes of Health Research CGS-D award. Dr Webb is a consultant to Edwards Lifesciences, and received research support from Edwards Lifesciences, Boston Scientific, and Abbott. Dr Seidman is a consultant for Baylis Medical Technologies. J. Sathananthan has been a consultant to Edwards Lifesciences, Anteris, Medtronic, and is an employee of Boston Scientific. Dr Khan is a proctor for Edwards Lifesciences and Medtronic and has equity in Transmural Systems, and received educational grants from Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, and Philips. The other authors report no conflicts.
- Published
- 2024
- Full Text
- View/download PDF